Capricor sues Nippon Shinyaku over Duchenne drug 'pricing flaw' and launch prep
Capricor Therapeutics said Thursday it has filed a lawsuit against Nippon Shinyaku over a distribution and commercialization agreement for deramiocel, a cell therapy candidate for Duchenne muscular dystrophy (DMD) that’s getting a second chance at ...
May 8, 2026 07:00 AM EDT PharmaLaw Capricor sues Nippon Shinyaku over Duchenne drug 'pricing flaw' and launch prep Ayisha Sharma News Reporter Capricor Therapeutics said Thursday it has filed a lawsuit against Nippon Shinyaku over a distribution and commercialization agreement for deramiocel, a cell therapy candidate for … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that